glp-1 news employers CT Health | are facing mounting pressure from the growing cost of covering weight-loss drugs, as demand for medications like Wegovy and Meet @getcruxhealth, a benefits platform
Description
Pharmacotherapy Most patients will require oral hypoglycemic agents and/or insulin to control hyperglycemia, especially in advanced stages of liver disease
79 GastaldelliACusiKFernndez LandLBrayRBrouwersBRodrguez

Semaglutide commercializzato in due formulazioni indicate come antidiabetici: Ozempic (siringhe pronte alluso per iniezione sottocutanea) e Rybelsus (compresse)

Reimbursement and formulary status for GLP-1 RAs depend on: clinical endpoints (A1c and weight loss thresholds), tolerability and discontinuation rates, and increasingly, cardiometabolic outcomes

But pause

If you are finding one medication difficult to tolerate, switching is a clinical option worth discussing with your prescriber
